AXS vs JHG

AXS exhibits a weak Piotroski F-Score of 2/9, signaling significant financial health concerns, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the company trades at a low P/E of 8.53 versus sector average of 20.94, shows strong recent earnings growth (YoY +83.3%), and beats estimates consistently, with a favorable analyst target of $120.91. However, deteriorating technical trend (0/100), bearish insider activity, and weak liquidity ratios (Current Ratio: 0.70, Quick Ratio: 0.19) counterbalance valuation appeal. The stock appears reasonably valued near $102 but faces structural balance sheet risks and negative insider sentiment.

JHG presents a stark contradiction between valuation and operational health, highlighted by a weak Piotroski F-Score of 3/9. While the company exhibits explosive YoY earnings growth (244.6%) and trades significantly below its Graham Number ($62.47) and Intrinsic Value ($154.29), the low F-Score suggests deteriorating fundamental trends. This, combined with a very bearish technical trend (10/100) and low insider sentiment, indicates that the market is pricing in risks not immediately apparent in the growth metrics. The stock is a classic 'deep value' candidate that requires caution due to declining operational quality.